Cancer Profiling Market to Reach US$ 950 Mn in 2019, Breast Cancer Profiling Preeminent, Finds Fact.MR
Verfasser: ashwani_kailiya on Monday, 17 December 2018Cancer profiling market revenues surpassed US$ 900 million in 2018, according to Fact.MR’s latest study. Growing at a subdued 4% y-o-y, the study foresees absolute opportunity of over US$ 36 million in 2019. Steadily rising opportunities in cancer profiling market can be attributed to,
- Increasing disease burden of cancer worldwide
- Significant economic burden associated with cancer diagnosis and treatment
- Growing R&D investments to develop effective cancer diagnostics
- Increasing importance of precision medicine adoption and reliance of cancer profiling
According to the study, cancer profiling market revenues continue to remain consolidated in North America. Of the estimated new cases, breast cancer accounts for over 15% and colorectal cancer for about 8% new cases. As breast and colorectal cancers are few of the leading causes of death in North America, collectively they register nearly 70% of total regional cancer profiling revenues.
Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=358